Are patients with Glanzmann thrombasthenia and the Bernard-Soulier syndrome protected against atherosclerosis?
Nurden
A T
AT
Laboratoire de Pathologie Cellulaire de l'Hémostase, UMR 5533 CNRS, Hôpital Cardiologique, Pessac, France.
Nurden
P
P
George
J N
JN
D001161:Arteriosclerosis / Q000097:blood / Q000453:epidemiology* / Q000209:etiology / Q000503:physiopathology; D001606:Bernard-Soulier Syndrome / Q000097:blood / Q000453:epidemiology* / Q000208:ethnology; D001791:Blood Platelet Disorders / Q000453:epidemiology / Q000235:genetics; D001792:Blood Platelets / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism; D003594:Cytoplasmic Granules / Q000378:metabolism; D004252:DNA Mutational Analysis; D004198:Disease Susceptibility; D005006:Ethnicity / Q000235:genetics; D005260:Female; D018740:Genetic Heterogeneity; D006133:Growth Substances / Q000378:metabolism; D006801:Humans; D008297:Male; D009154:Mutation; D009203:Myocardial Infarction / Q000453:epidemiology; D010973:Platelet Adhesiveness; D010974:Platelet Aggregation; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000235:genetics / Q000502:physiology; D019038:Platelet Glycoprotein GPIb-IX Complex / Q000235:genetics / Q000502:physiology; D010980:Platelet Membrane Glycoproteins / Q000172:deficiency* / Q000235:genetics / Q000502:physiology; D019030:Receptors, Vitronectin / Q000235:genetics / Q000502:physiology; D017384:Sequence Deletion; D013915:Thrombasthenia / Q000097:blood / Q000453:epidemiology* / Q000208:ethnology
D016207:Cytokines; D006133:Growth Substances; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D019038:Platelet Glycoprotein GPIb-IX Complex; D010980:Platelet Membrane Glycoproteins; D019030:Receptors, Vitronectin